Key Highlights
•
In older adults, higher variability in blood pressure from beat to beat is linked to a greater burden of small vessel disease in the brain. This finding is significant because it suggests that unstable blood pressure, not just high average pressure, may contribute to the silent damage in brain vessels that can lead to cognitive decline.
Source →
•
The negative impact of blood pressure variability on cognitive test scores is only evident when the brain’s natural ability to regulate its own blood flow (cerebral autoregulation) is impaired. This interaction is crucial as it identifies a specific group of older adults whose brains are more vulnerable to the harmful effects of blood pressure swings, independent of visible small vessel disease on scans.
Source →
•
A new position paper argues that pain medicine must urgently become a frontline discipline in preventing and managing opioid use disorder (OUD). This is a critical shift because many people with OUD also experience pain, and standard pain treatments have contributed to the current opioid crisis, requiring a new, integrated approach to care.
Source →
•
The paper recommends core strategies like using trauma-informed communication, continuing addiction medication during acute care, and employing tailored, non-opioid pain relief methods. Implementing these changes is vital to reduce harm and provide equitable, effective pain management for people with or at risk of opioid addiction, moving beyond simply prescribing opioids.
Source →
•
A study comparing cell and gene therapy (CGT) regulation and payment in China and the US finds that the US uses a market-driven model with commercial insurance, while China employs a government-led model through national medical insurance. Understanding these differences is important for developing global strategies to make these advanced, often expensive therapies more accessible and affordable worldwide.
Source →
•
Both countries face common challenges, including a lack of long-term safety and effectiveness data and unequal access to treatments across different regions. Addressing these shared dilemmas through international collaboration on regulation and payment models is key to ensuring the benefits of cutting-edge cell and gene therapies reach all patients who need them.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
